Counterweight Ventures LLC Boosts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Counterweight Ventures LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,761 shares of the financial services provider’s stock after buying an additional 245 shares during the quarter. Counterweight Ventures LLC’s holdings in iShares Biotechnology ETF were worth $791,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Blue Fin Capital Inc. boosted its stake in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after buying an additional 74 shares during the period. Crewe Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares during the last quarter. Apexium Financial LP increased its holdings in shares of iShares Biotechnology ETF by 3.8% in the fourth quarter. Apexium Financial LP now owns 2,223 shares of the financial services provider’s stock valued at $302,000 after purchasing an additional 82 shares during the period. Perkins Coie Trust Co lifted its holdings in shares of iShares Biotechnology ETF by 0.3% during the second quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock worth $3,457,000 after purchasing an additional 83 shares during the period. Finally, Optimum Investment Advisors grew its position in iShares Biotechnology ETF by 2.9% in the 2nd quarter. Optimum Investment Advisors now owns 3,024 shares of the financial services provider’s stock valued at $415,000 after buying an additional 85 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $142.75 on Friday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17. The firm has a fifty day moving average of $144.12 and a two-hundred day moving average of $138.01.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.